🔔 Good morning, and welcome to Telda Lens — your daily pulse on Egypt’s markets.
Today: We have the latest financial results for Cleopatra Hospitals Group.
But, before we start, a quick note: The Egyptian Exchange officially announced a halt of trading from Thursday, 19 March, through Monday, 23 March in observance of Eid al-Fitr. Trading is scheduled to resume on Tuesday, 24 March. The Telda team wishes you a very Happy Eid with loved ones.
Market overview
EGX Pulse
🔔 EGX30 ended +1.9% by market close at 46,054 points, the EGX70 rose 1.0% to 12,511 points, and the EGX100 rose 1.1% to reach 17,488 points.
💸 The number of transactions reached 108,485 spread across 1,021,504,306 stocks leading to a turnover of EGP 4.962 billion.
🏷️ Local investors were the only net buyers.
📈 Top gainers for the market as a whole included Creast Mark For Contracting And Real Estate Development (+10.1%), International Agricultural Products (+7.7%), and U Consumer Finance (+7.7%).
📉 Top losers for the market included AJWA for Food Industries company Egypt (-6.9%), Gogreen for Agricultural Investment (-6.6%), and El Ahram Co. For Printing And Packing (-2.9%).
⬆️ Top gainers for EGX30 included ADIB (+6.1%), Fawry (+4.8%), and Heliopolis Housing (+4.0%).
⬇️ Top losers included Amoc (-2.2%), Valmore Holding -EGP (-2.0%), and Edita (-1.4%).
Other Important Stats:
🧈 24K Gold reached EGP 8,347 per gram, down 0.4% day-on-day but up 10.7% month-on-month.
💲 The USD reached EGP 52.3 at the National Bank of Egypt.
Corporate Corner
Cleopatra Hospitals reports an 18% rise in net profit for 2025
Cleopatra Hospitals Group (CLHO) reported a consolidated net profit of EGP 968 million for 2025, up 18% year-on-year, according to its latest financial results.
.Revenue climbed 33% in 2025:
Total consolidated revenue reached EGP 7.23 billion, marking a 33% increase compared with the same period last year. Performance was broad-based across all facilities, driven by a 12% increase in total cases served to 1.5 million, strategic price adjustments, and an enhanced case mix.
Facility performance highlights:
Cleopatra Hospital: The largest contributor, generating record revenues of EGP 2.46 billion (+29% YoY), accounting for 33% of consolidated revenue.
Cairo Specialized Hospital: Recorded revenues of EGP 1.58 billion (+34% YoY), supported by the expansion of its dialysis unit and the launch of a Bone Marrow Transplantation unit.
Al-Shorouk Hospital: Brought in EGP 1.07 billion (+32% YoY), bolstered by its repositioning as an Oncology Center of Excellence.
Nile Badrawi Hospital): Generated EGP 1.06 billion (+28% YoY), driven by strong performance in nephrology, cardiology, and urology.
El Katib Hospital: Revenues reached EGP 354 million (+38% YoY), following a full operational turnaround.
Polyclinics & Others: CHG for Medical Services (Polyclinics) and other ancillary businesses continued to expand the Group's referral ecosystem and geographic reach.
Details for the fourth quarter:
For the fourth quarter of 2025, total consolidated revenue rose to EGP 1.91 billion, up 20% year-on-year from EGP 1.59 billion in 4Q 2024. Net profit for the quarter was EGP 129 million, a 40% decline versus 4Q 2024, primarily due to one-off general and administrative expenses related to the launch of new facilities and digital infrastructure.
Strategic outlook:
The Group has clear visibility on a compelling growth trajectory, with plans to more than double revenues by 2028 compared to 2025 levels. This growth will be underpinned by the ramp-up of the EGP 3.5 billion Cleopatra El Tagamoa hospital it launched at the end of last year (which increased the total network capacity by approximately 30%) and the 200-bed expansion of Cleopatra October Hospital.
Management noted that it has already surpassed the EGP 1 billion revenue mark within the first 45 days of 2026, reflecting strong early-year momentum.
Stock performance:
The company share price is up 40% over the past 12 months. However, management noted yesterday that the current share price does not fully reflect the strength of their brand, the quality and scale of growing bed capacity, or the substantial capital invested to position the Group for accelerated growth into 2026 and beyond.
Macro view
Egypt in focus
💸 The government is preparing, right after the Eid break, to lock in a plan to either sell stakes in or list at least 20 state-owned companies, aiming to bring in USD 3–4 billion by year-end, a senior official tells EnterpriseAM. The move is designed to shore up foreign currency inflows and wrap up commitments to the International Monetary Fund regarding the government’s privatization program, with offerings expected to focus on minority stakes in stronger-performing firms through the EGX rather than outright sales.
💶 The European Commission has allocated EUR 8 million in aid targeting vulnerable groups in Egypt, focusing on education access for out-of-school children and disaster preparedness programs. The funding comes as part of a broader EUR 458 million regional package largely directed toward conflict-affected countries, while Egypt and Jordan receive comparatively smaller shares.
